Skip to content

Mucuna pruriens and mood: grade D

Preliminary evidence. Direction: No effect.

D Preliminary

Why this grade

Rubric condition met: No controlled human mood outcome data for Mucuna; animal studies only

A 2024 review of mood-related research on Mucuna drew its evidence from animal models and said clinical trials are needed. Parkinson's disease trials scored non-motor symptoms against active levodopa, not placebo, in a clinical population, so they do not test mood in healthy adults. As of November 11, 2026 we found no randomized trials of Mucuna on mood in healthy adults (PubMed and Europe PMC searches, 2026-11-11).

How we grade evidence

Studies this grade rests on

EffectMixedNo effectSize shows participants (n)202020252030RCTNarrative review…Cilia 2026, 2026: RCT, n = 32, result not recordedMata-Bermudez 2024, 2024: narrative review of animal studies, n not recorded, result not recorded
each study this grade rests on, by publication year and design. Solid: effect versus the comparator; half-filled: mixed; hollow: no effect; dashed: result not recorded yet. Larger marks had more participants.
Show the numbers
StudyYearDesignParticipantsResult
Mata-Bermudez 20242024narrative review of animal studiesnot recordedresult not recorded
Cilia 20262026RCT32result not recorded

Mucuna pruriens, a Possible Treatment for Depressive Disorders.

Mata-Bermudez A, Diaz-Ruiz A, Silva-García LR. Mucuna pruriens, a Possible Treatment for Depressive Disorders Neurol Int, 2024. PMID 39585071

Result not recorded
Design
Narrative review of animal studies
Population
Animal models
Funding
Universidad Nacional Autonoma de Mexico DGAPA-PAPIIT IN228223

Mucuna pruriens in untreated Parkinson's disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial.

Cilia R, Cham M, Obese V. Mucuna pruriens in untreated Parkinson's disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial J Parkinsons Dis, 2026. PMID 41269916

Result not recorded
Design
Randomized, open-label, multicenter phase 2 trial, 12 months
Sample
n = 32
Population
Adults with untreated Parkinson's disease in sub-Saharan Africa (clinical population)
Funding
Fondazione Pezzoli per la Malattia di Parkinson (Crossref funder record)

Search and history

Search (): (mucuna[tiab] OR "velvet bean"[tiab]) AND (depress*[tiab] OR mood[tiab] OR motivation[tiab] OR anhedonia[tiab]) AND (trial[tiab] OR randomized[tiab] OR placebo[tiab])

  • Graded D (proposed): Proposed in the monograph draft
  • D to D (approved): Editor sign-off November 13, 2026: grade matches the editor-approved final page